AstraZeneca PLC (AZN.US) Suspends UK Investment Plan, Faces Fresh Rating Downgrade

Stock News
2025/09/15

Swedish bank Handelsbanken has downgraded AstraZeneca PLC (AZN.US) from "buy" to "hold," citing concerns that the company's target of achieving $80 billion in total revenue by 2030 appears overly optimistic. The downgrade comes amid reports that the pharmaceutical giant has suspended major investments in its home market. The UK's largest listed company has become the latest pharmaceutical firm to scale back operations in the country. A company spokesperson confirmed late Friday that it has suspended a £200 million (approximately $272.12 million) investment plan for its Cambridge research and development center, delivering a significant blow to the UK government.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10